Responsiveness of Hindi Version of Oral Health Impact Profile for Periodontitis (OHIP-P-HIN)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorPostgraduate Institute of Dental Sciences Rohtak
About this trial
The distribution- and anchor-based methods will be used to estimate the Minimal Important Difference (MID) of the OHIP-P-HIN. Two established distribution-based approaches, the standardized effect size (ES) and standardized response mean (SRM) will be calculated. The ES is calculated by dividing the mean change scores in the OHIP-P-HIN from baseline by the standard deviation of the baseline scores. And the SRM are computed as ratios of the mean change score divided by its standard deviation. The anchor-based approach will be applied by using the global transition scale as the anchor.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
≥18 years of age
patients able to understand and complete questionnaires independently
confirmed diagnosis of periodontitis
Disqualifiers
Patients with systemic diseases such as acquired immunodeficiency syndrome or diabetes mellitus
pregnancy
required prophylactic antibiotic coverage prior to dental treatment,
patients with bleeding disorders
Trial design
Design model
Single group
Treatments tested in this trial
Non Surgical Periodontal Therapy
Procedure/SurgeryFull mouth subgingival instrumentation will be done
Treatment groups
106 Participants
are divided into 1 treatment groupGroup A: Non Surgical Periodontal TherapyOther 1 intervention
Trial outcomes
Primary outcomes
1
Minimal Important Difference (MID)
The distribution- and anchor-based methods will be used to estimate the MID. Two established distribution-based approaches, the standardized effect size (ES) and standardized response mean (SRM) will be calculated. The anchor-based approach will be applied by using the global transition scale as the anchor.
Time frame
6 weeks after completion of Non surgical Periodontal therapySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov